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Objective: Popliteal artery aneurysms (PAA) are frequently treated with ligation and exclusion bypass grafting. It is
assumed that these aneurysms will shrink and remain asymptomatic. This may not always be true. We sought to elucidate
the fate of excluded PAA over time.
Methods: Data for all PAAs treated with ligation and exclusion bypass grafting between 1986 and 1999 were retrospec-
tively reviewed. Computed tomography (CT) scans and duplex ultrasound scans provided aneurysm patency data and
maximal transverse diameter measurements of the popliteal artery during late postoperative follow-up. This information
was compared with that from similar preoperative studies.
Results: Forty-one patients (39 men, 2 women) underwent 57 ligation and exclusion bypass grafting procedures. Both
preoperative and late postoperative (mean, 4.0 years; range, 0.43-13.5 years) CT scans or duplex ultrasound scans were
available for review of 25 PAAs in 18 patients (ages 42-80 years; mean, 63 years). Preoperative PAA size ranged from 14
to 45 mm (mean, 28.7 mm). In late follow-up, 12 (48%) PAA had decreased in size (mean, 7.3 mm), 5 (20%) remained
unchanged, and 8 (32%) increased in mean transverse diameter (mean, 5.9 mm). One large aneurysm increased by 50%.
Contrast material enhancement was identified in the excluded sac in 11 aneurysms.
Conclusions: PAA treated with ligation and exclusion bypass grafting often expand and can become symptomatic. This
may be analogous to type II endoleak or endotension noted after aortic endovascular repair. We recommend PAA excision
or endoaneurysmorrhaphy when feasible. (J Vasc Surg 2003;37:954-9.)
Current recommendations for management of popli-
teal artery aneurysms (PAA) include exclusion of the aneu-
rysm with proximal and distal ligation combined with re-
verse saphenous vein bypass grafting around the affected
segment.1 This procedure has come to be known as ligation
and exclusion bypass grafting. It is usually accomplished
through the medial approach, which enables the surgeon to
operate without using the potentially hazardous and more
technically demanding posterior approach.2-5 The medial
approach to ligation and exclusion bypass grafting is partic-
ularly advantageous when treating large aneurysms in the
absence of vein or nerve entrapment.3,5
Enlargement and even rupture of a popliteal aneurysm
after ligation and exclusion bypass grafting has been expe-
rienced at our institution and has been reported else-
where.6-8 Retrograde flow through collateral branches can
fill PAA and is likely responsible for continued enlargement
after treatment. We performed a retrospective study of the
fate of PAA treated with ligation and exclusion bypass
grafting and sought the incidence of continued growth and
symptoms.
METHODS
Data for all patients who underwent surgery to treat
PAA at Northwestern Memorial Hospital between 1986
and 1999 were reviewed. PAA treated with ligation and
exclusion bypass grafting were isolated from those treated
with resection or endoaneurysmorraphy. Only PAA with
preoperative measurements were included in the final anal-
ysis. Maximal transverse diameter of PAA was determined
preoperatively and at follow-up with computed tomogra-
phy (CT), color flow duplex scanning (CFD), magnetic
resonance imaging (MRI), conventional angiography, or
magnetic resonance angiography (MRA).
Patients returning for routine clinic follow-up were
preferentially examined with contrast material-enhanced
CT, although MRI or MRA and CFD were acceptable
alternatives. Two independent observers (a radiologist and
a surgeon) measured PAA maximum transverse diameter,
determined bypass graft patency, and identified radio-
graphic contrast or blood flow within the aneurysm sac.
CFD examinations were performed in an Intersocietal
Commission for Accreditation of Vascular Laboratories-
approved vascular laboratory. CFD examinations included
grayscale scanning, color Doppler scanning, and spectral
scanning to determine bypass graft patency and to detect
flow within the aneurysm sac. Statistical analysis was per-
formed with SPSS version 10.1 (SPSS, Chicago, Ill). P 
.05 was considered statistically significant.
Clinical features. Forty-one patients (39 men, 2
women) underwent 57 ligation and exclusion bypass graft-
ing procedures. Permission to review patient characteristics
and data was requested, and was granted by the local
Institutional Review Board at Northwestern University
before undertaking this retrospective review. Both preop-
erative and late postoperative (mean, 4.0 years; range,
0.4-13.5 years) studies were available for 25 PAA in 18
patients. Demographic data for these 18 patients are pre-
sented in Table I. Most patients were elderly male smokers
with hypertension and other risk factors for peripheral
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vascular disease, eg, coronary artery disease and hypercho-
lesterolemia. Seventy-two percent of patients had at least
one other aneurysm, most commonly a contralateral PAA.
Clinical characteristics of the patients and indications
for the original ligation and exclusion bypass grafting pro-
cedure for the 25 individual PAA are shown in Table I.
Approximately half of all PAA were symptomatic, with
most patients reporting symptoms related to acute occlu-
sion and limb ischemia. No PAA was ruptured at presenta-
tion. Preoperative angiography was performed in 17 of 25
patients, and this study the only source of determination of
preoperative PAA size in 1 patient (PAA 16, Table II).
Runoff was variable, but all patients had at least one-vessel
runoff (Table I). One patient received preoperative throm-
bolysis because of acute thrombosis. For most aneurysms,
preoperative measurements were based on either CT or
CFD (Table III). Preoperative popliteal aneurysm diameter
ranged from 14 to 45 mm (mean, 28.7 mm). Most (21 of
25) were repaired with a vein graft conduit.
RESULTS
Mean aneurysm follow-up was 4.3 years (range, 0.4-
13.5 years). Late follow-up PAA measurements were based
on CT, CFD, MRI, or MRA (Table III). All 18 patients
maintained a viable limb ipsilateral to the PAA. Of the 25
PAAs, 12 (48%) decreased in mean transverse diameter
(mean, 7.3 mm), 5 (20%) remained unchanged, and 8
(32%) increased (mean, 6 mm). One large aneurysm in-
creased by 50%; this patient underwent endoaneurysmor-
rhaphy through a posterior approach because of symptoms
related to local compression. Aneurysm growth rate ranged
from 0.15 to 6.4 mm per year (average, 1.4 mm per year).
In 6 of 18 patients (33%), PAA showed growth over the
study period. No PAA had ruptured in any of the 18
patients at follow-up.
Twenty of 23 bypass grafts (87%) remained patent at
follow-up. Patency was presumed at physical examination
but could not be proved radiographically in 1 patient, in
whom only non-contrast-enhanced CT of bilateral PAA
was performed, without duplex scanning. Of the 3 grafts
that became occluded, two were polytetrafluoroethylene
grafts, and only 1 of the 3 patients experienced symptoms
of acute lower extremity ischemia (PAA 13). In 1 of these
patients the aneurysm decreased in size; in another the PAA
remained stable; and in the third patient the PAA increased
by 7% (Table II).
At follow-up, flow was identified in the excluded sac in
12 of 16 PAA examined with contrast-enhanced CT or
CFD. No trend was noted to suggest that presence of
contrast material or flow within the aneurysm sac predis-
posed to growth of PAA after ligation and exclusion bypass
grafting (Table IV). Small preoperative aneurysm size was,
on the other hand, associated with continued PAA growth,
although this finding was not statistically significant. Con-
trary to this trend, however, 1 large aneurysm (PAA 14)
grew by 50%.
DISCUSSION
The fate of excluded PAA is extremely variable, but
they can continue to expand, become symptomatic, and
require reintervention. Popliteal aneurysm size can increase
or decrease by as much as 50%. It remains unclear why some
aneurysms respond well to treatment or remain stable and
others continue to expand.
Growth of PAA after ligation and exclusion bypass
grafting may be due to phenomena analogous to type II
endoleak noted after endovascular repair of abdominal
aortic aneurysms. After apparent successful endovascular
repair of aneurysms with stent grafts, endoleak type, size,
and pressure have repeatedly been associated with aneu-
rysm growth and even rupture.9-13 Retrograde filling of the
Table I. Patient and PAA characteristics at late follow-up
n %
Patients 18
Male 17 94
Age at PAA diagnosis (y)
Mean 63
Range 42-80
Clinical features
Associated vascular disease or risk factors
PV occlusive disease 6 33
History of tobacco use 10 56
COPD 2 11
Hypertension 12 67
Hypercholesterolemia 3 17
Diabetes mellitus 1 6
History of MI 4 22
CRI 0
History of CABG 3 17
History of CVA 1 6
Other aneurysms 13 72
Aortoiliac artery 8 44
Femoral artery 5 28
Contralateral popliteal artery 13 72
PAA
Total 25 100
Symptomatic 12 48
Claudication 6 24
Rest pain 4 16
Gangrene 0
Ulceration 1 4
Blue toe syndrome 1 4
Rupture 0
Acute occlusion 8 32
Asymptomatic 13 52
Conduit used
Vein graft 21 84
PTFE graft 4 16
Preoperative angiography 17 68
Tibial vessel runoff
0 0/17 0
1 5/17 29
2 2/17 12
3 6/17 35
NA 4/17 24
PAA, Popliteal artery aneurysm; COPD, chronic obstructive pulmonary
disease; MI, myocardial infarction; CRI, chronic renal insufficiency; CABG,
coronary artery bypass grafting; CVA, cerebrovascular accident; PTFE,
polytetrafluoroethylene; NA, information not available.
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PAA sac from geniculate collateral vessels may contribute
to continued elevated pressure within the aneurysm and
therefore to aneurysm expansion.
An alternative explanation for continued postoperative
PAA expansion could be the poorly defined phenomenon
of endotension. Resnikoff et al,14 Bade et al,15 and Ruurda
et al16 have reported continued aortic or iliac aneurysm
growth, and even rupture, after exclusion bypass grafting,
despite documented complete thrombosis of the aneurysm
or ligation of multiple collateral branches. Endotension, a
term introduced in 1999,17 is constant pressure within an
aneurysm sac without an identifiable source of blood flow
perfusing the sac.18,19 This phenomenon would explain the
growth of one of the aneurysms in our series (PAA 24)
despite complete thrombosis of the sac.16,20 Endotension,
on the other hand, could represent missed flow inside the
aneurysm sac that cannot be seen on contrast-enhanced CT
scans.21
CFD can be useful for surveillance of excluded PAA.
Duplex scanning can not only enable detection of growth,
but can also be used to evaluate for retrograde collateral
blood flow into the excluded aneurysm sac. CFD is sensi-
tive for detecting type II aortic endoleak.22,23 Similarly,
CFD can easily characterize collateral flow into an excluded
PAA sac and detect the source; typically PAAs have feeding
vessels that arise from the geniculate arteries or from termi-
nal branches of the profunda femoris artery.
We advocate early intervention to prevent symptoms of
local compression or rupture if growth of a PAA can be
demonstrated after ligation and exclusion bypass grafting,
regardless of the cause (Figure). Alternatively, in elderly
patients at high-risk we choose close observation until
compressive symptoms arise, because risk for embolization
has been eliminated. If collateral filling of the excluded
PAA sac is believed to be the cause of continued growth,
Table II. Preoperative and follow-up data
Aneurysm
Initial
diameter
(mm)
Follow-up
diameter
(mm)
Percent
change
Follow-up
(y)
Contrast
material
filling
excluded
PAA on
CT scan
Graft
patent at
follow-up
1 22 15 32 3.7 Yes Yes
2 40 38 5 2.7 Yes Yes
3 45 30 33 7.2 Yes Yes
4 15 14 7 1.0 NA* Yes
5 19 22 16 6.1 Yes Yes
6 27 29 7 4.0 Yes Yes
7 19 16 15 2.7 NA Yes
8 25 22 12 6.0 NA Yes
9 35 35 0 1.1 Yes Yes
10 25 32 28 1.1 Yes Yes
11 22 22 0 0.8 NA NA
12 19 19 0 0.8 NA NA
13 30 32 7 13.5 NA No
14 40 60 50 9.1 NA Yes
15 40 18 55 5.0 NA Yes
16 45 32 29 0.9 NA No
17 38 38 0 1.0 No Yes
18 37 33 11 0.4 Yes Yes
19 30 16 47 3.7 No Yes
20 29 29 0 1.9 Yes No
21 14 19 36 9.0 Yes Yes
22 15 20 33 10.6 Yes Yes
23 41 37 10 0.4 Yes Yes
24 17 20 18 5.1 No Yes
25 29 28 3 3.2 No Yes
Mean of total 29 27 4.0
PAA, Popliteal artery aneurysm; NA, information not available because follow-up study was duplex ultrasound scan or non-contrast-enhanced CT scan.
Table III. Preoperative and postoperative diagnostic
methods used to obtain measurements of individual PAA
PAA (N  25) n %
Preoperative study
CFD 2 8
CT 22 88
Angiography 1 4
Postoperative study
CFD 6 24
CT 18 72
Angiography 0
MRI/MRA 1 4
PAA, Popliteal artery aneurysm; CFD, color flow Doppler scanning; CT,
computed tomography; MRI, magnetic resonance imaging; MRA, mag-
netic resonance angiography.
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several treatment options exist. The best alternative contin-
ues to be open repeat exploration with resection or endoa-
neurysmorraphy, but this risks serious nerve, vein, or lym-
phatic damage. A newer, perhaps safer, alternative is
derived from the aortic endograft experience and involves
percutaneous injection of a prothrombotic agent to close
persistent branch flow. Injectable materials used for this
technique include thrombin,24 ethylene-vinyl-alcohol co-
polymer (Onyx, MicroTherapeutics, Inc, Irvine, Calif),25
biologic glue, Lipiodol (Guerbet, Roissy, France) or Mi-
crocoils (Cook, Charenton, France),26 and absorbable
thrombogenic sponge.27 As endovascular alternatives for
repair of PAA become available,28-30 these adjunct proce-
dures derived from the aortic endovascular experience may
become especially relevant for treatment of persistent PAA
sac growth.
Risk factors for aortic endoleak include multiple patent
lumbar arteries and large initial aneurysm size.31,32 On the
contrary, we found that small initial aneurysm size may be a
risk factor for continued PAA expansion. Since small aneu-
rysms are easier to resect, we find it reasonable to attempt
resection, or at least side branch occlusion, when it can be
done safely at the initial operation. Of interest, we found no
trend to suggest that an incompletely thrombosed sac or
multiple retrograde-filling side branches predispose PAA to
grow after operative exclusion. Graft patency and contrast
filling into the excluded aneurysm sac could not be found
to correlate with either increase or decrease in maximum
transverse diameter.
Long-term surveillance of excluded PAA is advocated
in this study and others that have documented progression
of aneurysm disease despite ligation and exclusion bypass
grafting with interruption of feeding collateral vessels.7,8,33
Despite only small size being a possible risk factor for
growth, we recommend close follow-up of all PAA after
ligation and exclusion bypass grafting, with contrast-en-
hanced CT or CFD. If patent, thrombosis of the PAA with
injection of a thrombotic agent, repeat operative endoan-
eurysmorrhaphy, or resection may be indicated. To prevent
the risk altogether, in properly selected patients we recom-
mend PAA excision or endoaneurysmorrhaphy at the initial
Follow-up CT (A) and angiographic (B) images show displace-
ment of the vein graft and compression of adjacent structures
subsequent to ligation and exclusion bypass grafting. Collateral
filling of the PAA is seen on the CT scan.
Table IV. Relationship of contrast material filling PAA
sac and initial aneurysm size to growth of PAA after
ligation and exclusion bypass grafting
Aneurysm
stable or
shrinking
Aneurysm
growing P
Contrast material
fills sac
7 5 1.0*
PAA thrombosed 3 1
Large PAA† 11 2 0.154*
Small PAA‡ 6 6
PAA, Popliteal artery aneurysm.
*2 test with Yates correction.
†Initial PAA diameter equal to or greater than mean.
‡Initial PAA diameter less than mean.
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operation when feasible and deemed safe by the operating
surgeon.
Popliteal aneurysm ligation and exclusion bypass graft-
ing through a medial approach is preferred by many sur-
geons because of its technical ease, safety, and preservation
of valuable collateral vessels. The greater saphenous vein is
easily accessible for use as a conduit through this incision.
The tibial vessels can also be easily dissected for distal bypass
in case of preoperative tibial vessel occlusion, and the
superficial femoral artery can be used for inflow, as the
proximal popliteal artery is often dilated or occluded.4,33
Through an extended medial incision, with transection
of the sartorius, gracilis, semimembranosus, and semi-
tendinosus tendons, the entire popliteal artery is ex-
posed.34 The aneurysm can then be resected with mini-
mal knee joint weakness or instability. This modification
of the limited medial incision technique4 now routinely
used for ligation and exclusion bypass grafting is an
alternative approach that some may consider advisable at
the initial operation. The posterior approach to popliteal
aneurysm repair also continues to be an excellent option
in many patients for initial repair, but particular caution
must be exercised. Early experience with this technique
showed a high incidence of tibial nerve and especially
popliteal vein injury with aneurysm resection, because
these structures are often densely adherent to large an-
eurysms.33,35 Treatment with endoaneurysmorrhaphy
without attempting to resect the aneurysm sac has been
effective in preventing these complications in our recent
cases.
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DISCUSSION
Dr Alexandre d’Audiffret (Minneapolis, Minn). I may have
missed it, but did you see aneurysmal growth without evidence of
contrast in the aneurysm during follow-up?
Dr James Ebaugh. Yes, we did in 1 patient.
Dr d’Audiffret. I think that is very interesting if you want to
equate this to endotension and endoaneurysmal repair.
Dr Tim Baxter (Omaha, Neb). A couple questions I have.
Could you tell us one thing, in terms of recommending excision of
these, how much do you think that will increase morbidity associ-
ated with this operation if that is your approach to this problem?
Dr Ebaugh. There is a risk of tibial nerve or popliteal vein
injury in the operation. If it does not look like it is possible, then
excision should not be performed. The incidence of growth might
be 32%, but in terms of these becoming clinically significant, the
number is very much less, so I do not think that anyone should
excise the popliteal aneurysm if it does not look like it is safe to do
so intraoperatively.
Dr Bill Turnipseed (Madison, Wis). I find this kind of an
intriguing concept, and the first thing that came to mind was your
last conclusion that perhaps this was a surrogate of a disease that we
have created, with endoleak being either the equivalent of a type II
leak or perhaps a bizarre physiologic form of endotension. One of
the things that is very difficult to do in preoperative assessment of
these lesions is to get a good view of collaterals. I think it is a very
haphazard event that may or may not be documented short of the
major geniculates above the aneurysm, which you often see. You
know, the one picture that you showed with CT contrast looked
like you probably missed a little side branch vessel that would
backleak over time. The question, I think perhaps you have already
answered, but in the larger popliteal aneurysms, to begin with
there is probably an argument for doing endoaneurysmorrhaphy
for the very issues you raise concern about, that is, either venous
compression or neural compression. The point about the fact that
small aneurysms do not very often do this would suggest that
probably in the majority of cases we, like you have suggested, do
not have to change our treatment algorithm. Have you given
thought to, or seen any evidence to suggest, perhaps instead of the
bypassed grafts, the ones that are treated like an aortic aneurysm,
where you put an interposition graft in and then close the aneu-
rysm sac around that, like the PTFEs, where vein is either not
available or not of adequate diameter, that these aneurysm closures
have expanded? This would be a lot more comparable to the
endoleaks that we see in the endografts where you have a graft put
in at either side. You do not see any backbleeding. You sew the cuff
over that graft. Have you seen any of those expand, refill, or
rupture?
Dr Ebaugh. Those patients were excluded in the initial pa-
tient selection for the study, and so we do not have any patients like
you described. If the graft was placed in the aneurysm in the
operation, I would imagine that the collaterals would be ligated at
that time, and the continued expansion would never be an issue.
Dr William Flinn (Baltimore, Md). I am getting a little
confused here today, and that is happening more often to me
nowadays. I was really gratified this morning, because I thought Dr
Zarins and his California colleagues had finally proven once and for
all that size does not matter. They can put an endograft in the
abdominal aorta, and even though it keeps growing, you do not
have to do anything about it because it is not going to rupture, and
you do not have to change the operation you are doing. Here you
are telling us that if the popliteal aneurysm keeps growing you
really need to do something about it, and you might even need to
change the whole operation. Maybe you could clarify that for me.
Dr Ebaugh. One thing I would like to discuss is, the rate of
growth is very slow in these aneurysms, and the 1 patient that did
experience 50% growth of his aneurysm over 9 years grew on
average only 2 mm per year, and the other patients grew at
approximately 1 mm per year, out of those that did grow. Regard-
ing the clinical significance of this, I think that we should not
intervene on somebody who does not have symptoms, and we
should not use just the simple fact that they are growing as an
indication for reoperating on these patients.
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